Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alzheimer's
Biotech
Sanofi signs 2nd biotech deal of the day
Sanofi is paying Adel $80 million in cash, with the total deal potentially reaching up to $1.04 billion, plus royalties.
Gabrielle Masson
Dec 15, 2025 5:50pm
Lilly calls for improvements to Alzheimer's testing in Europe
Oct 7, 2025 9:30am
Pivotal, Wellcome Leap invest $100M in women's health research
Sep 10, 2025 10:35am
Novartis pens BioArctic neuro pact worth $30M upfront
Aug 26, 2025 8:30am
AstraZeneca culls neuroscience meds in Q1 clear-out
Apr 29, 2025 7:08am
Biogen axes asset from $7.3B buyout, plus Alzheimer’s prospect
Feb 12, 2025 9:53am
